(Bloomberg) -- A record surge in Moderna Inc.'s shares delivered a $5 billion blow to short sellers who had bet that the vaccine maker's years-long slump would continue.
Most Read from Bloomberg
Natalie Harp, Trump's Gatekeeper, Is at Center of Senator Jon Ossoff Clash
Bessent Deploys Debt Buybacks in Sign of Concern Over Yield Rise
Trump Delays Canada Tariffs at 11th Hour, Saying Deal Close

#senator